Lessons learned and real-world insights from implementing neutralizing monoclonal antibody programs for treatment of COVID-19

Lessons learned and real-world insights from implementing neutralizing monoclonal antibody programs for treatment of COVID-19

Coronavirus disease-2019 precipitated the rapid deployment of novel therapeutics, which led to operational and logistical challenges for healthcare organizations. Four health systems participated in a qualitative study to abstract lessons learned, challenges, and promising practices from implementin...

Full description

Saved in:
Bibliographic Details
Main Authors: Nalini Ambrose, Alpesh N. Amin, Brian Anderson, Adam Aten, Brian Canter, Daniel Chow, Matthew D’Ambrosio, Risa Danan, Ashley L. Drews, Fraser W. Gaspar, Rachele Hendricks-Sturrup, John O’Horo, Raymund R. Razonable, Seth Roberts, Colin Shepard, Farhaan Vahidy, Brandon Webb, Jennifer Yttri
Format: Article
Language:English
Published: Cambridge University Press 2024-01-01
Series:Data & Policy
Subjects:
coronavirus disease-19
monoclonal antibodies
pandemic preparedness
Online Access:https://www.cambridge.org/core/product/identifier/S2632324924000774/type/journal_article
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.cambridge.org/core/product/identifier/S2632324924000774/type/journal_article

Similar Items